WallStreetZenWallStreetZen

NASDAQ: REPL
Replimune Group Inc Stock Ownership - Who owns Replimune Group?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Replimune Group Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher SarchiChief Commercial Officer2026-04-026,500$8.01
$52.07kSell
Kapil DhingraDirector2025-12-093,169$1.75
$5.55kBuy
Kapil DhingraDirector2025-12-093,169$10.40
$32.96kSell
Sushil PatelChief Executive Officer2025-12-0210,000$11.13
$111.30kSell
Konstantinos XynosChief Medical Officer2025-11-177,248$9.10
$65.96kSell
Christopher SarchiChief Commercial Officer2025-11-175,208$9.10
$47.39kSell
Emily Luisa HillChief Financial Officer2025-08-159,154$5.37
$49.16kSell
Christopher SarchiChief Commercial Officer2025-05-203,749$8.05
$30.18kSell
Philip AstleysparkeDirector2025-05-2032,279$8.06
$260.17kSell
Emily Luisa HillChief Financial Officer2025-05-202,535$8.05
$20.41kSell

1 of 2

REPL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when REPL insiders and whales buy or sell their stock.

REPL Shareholders

What type of owners hold Replimune Group Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP13.38%11,045,336$26.73MInstitution
Baker Bros Advisors LP12.25%10,116,095$24.48MInsider
Omega Fund IV LP11.43%9,436,760$22.84MInsider
Price T Rowe Associates Inc10.01%8,262,296$19.99MInstitution
Rtw Investments LP8.65%7,140,352$17.28MInstitution
Blackrock Inc7.35%6,069,633$14.69MInstitution
Hugo Alexander Slootweg5.72%4,721,449$11.43MInsider
Forbion Capital Fund III Cooperatief Ua5.72%4,721,449$11.43MInsider
Vanguard Group Inc4.57%3,776,198$9.14MInstitution
State Street Corp4.47%3,693,107$8.94MInstitution

1 of 3

REPL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
REPL65.28%34.72%Net SellingNet Selling
MIST22.52%11.49%Net SellingNet Selling
VYGR53.24%46.76%Net SellingNet Selling
HRTX55.61%44.39%Net Buying
KROS68.83%31.17%Net SellingNet Buying
View Top Biotech Stocks

Replimune Group Stock Ownership FAQ

Who owns Replimune Group?

Replimune Group (NASDAQ: REPL) is owned by 96.58% institutional shareholders, 51.36% Replimune Group insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Replimune Group shareholder, owning 10.12M shares representing 12.25% of the company. Baker Bros Advisors LP's Replimune Group shares are currently valued at $27.11M.

If you're new to stock investing, here's how to buy Replimune Group stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.